Regeneron Pharmaceuticals OverviewRegeneron Pharmaceuticals Income Tax
Income tax expense trends for REGN.
Quarterly Income Tax
$104.00M
↑ 8.00% YoY
As of Mar 2026
Annual Income Tax (TTM)
$733.50M
↑ 51.27% YoY
Trailing 12 months ending Mar 2026
Average Income Tax (Comparison Companies)
Income Tax History
Income Tax Comparison
Annual Income Tax Growth Rate (%)
Loading...
Annual Income Tax Growth (Absolute)
Loading...